{"id":14,"date":"2018-05-01T18:33:45","date_gmt":"2018-05-01T18:33:45","guid":{"rendered":"https:\/\/annualreport2022.ddev.site.php7-33.phx1-2.websitetestlink.com\/?page_id=14"},"modified":"2023-03-08T13:28:05","modified_gmt":"2023-03-08T19:28:05","slug":"influencing-public-policy","status":"publish","type":"page","link":"https:\/\/annualreport2022.ddev.site\/influencing-public-policy\/","title":{"rendered":"Influencing Public Policy"},"content":{"rendered":"
[vc_row css=”.vc_custom_1549915888425{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;background-position: 0 0 !important;background-repeat: no-repeat !important;}”][vc_column border_color=”#009bbf” css=”.vc_custom_1614031788665{margin-top: 50px !important;margin-bottom: 50px !important;border-top-width: 0px !important;border-right-width: 0px !important;border-bottom-width: 0px !important;border-left-width: 60px !important;padding-left: 40px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs” el_class=”.print”][vc_column_text css=”.vc_custom_1583957134489{margin-bottom: 0px !important;}”]\n
\n

Influencing Public Policy<\/h1>\n<\/div>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1549915909188{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;background-position: 0 0 !important;background-repeat: no-repeat !important;}”][vc_column border_color=”#009bbf” css=”.vc_custom_1583955587171{margin-top: 50px !important;margin-bottom: 50px !important;border-top-width: 0px !important;border-right-width: 0px !important;border-bottom-width: 0px !important;border-left-width: 50px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 30px !important;border-left-color: #009bbf !important;border-right-color: #009bbf !important;border-top-color: #009bbf !important;border-bottom-color: #009bbf !important;}” offset=”vc_hidden-lg vc_hidden-xs”][vc_column_text css=”.vc_custom_1583957173243{margin-bottom: 0px !important;}”]\n
\n

Influencing Public Policy<\/h1>\n<\/div>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1583955610090{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;background-position: 0 0 !important;background-repeat: no-repeat !important;}”][vc_column css=”.vc_custom_1583955658880{margin-top: 35px !important;margin-bottom: 35px !important;padding-right: 20px !important;padding-left: 20px !important;background-image: url(https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/title_bar_mobile.png?id=977) !important;}” offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm”][vc_column_text el_class=”mobile_title” css=”.vc_custom_1583955600074{margin-bottom: 0px !important;}”]\n
\n

Influencing Public Policy<\/h1>\n<\/div>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row equal_columns=”true” attached=”true” css=”.vc_custom_1675110822612{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background: #ffffff url(https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_hero_dt2x.jpg?id=5000) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1675110570974{padding-right: 0px !important;padding-left: 0px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” offset=”vc_col-lg-offset-0 vc_col-lg-12 vc_hidden-sm vc_hidden-xs”][mk_padding_divider size=”480″][vc_row_inner css=”.vc_custom_1551126783331{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner width=”1\/4″ css=”.vc_custom_1642800422512{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][vc_empty_space height=”25px”][\/vc_column_inner][vc_column_inner width=”3\/4″ css=”.vc_custom_1645128230200{padding-top: 0px !important;padding-bottom: 0px !important;background-color: rgba(255,255,255,0.36) !important;*background-color: rgb(255,255,255) !important;}”][vc_empty_space height=”50px”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row equal_columns=”true” attached=”true” css=”.vc_custom_1584032692153{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1614034297188{padding-right: 0px !important;padding-left: 0px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs” el_class=”.print”][vc_row_inner css=”.vc_custom_1675723808482{padding-top: 15px !important;padding-bottom: 45px !important;background-color: #5d6770 !important;}”][vc_column_inner width=”1\/4″ css=”.vc_custom_1584546280057{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][\/vc_column_inner][vc_column_inner el_class=”image_quotes” width=”3\/4″ css=”.vc_custom_1613502615410{margin-top: -15px !important;margin-right: 0px !important;margin-left: 0px !important;padding-top: 35px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-color: rgba(255,255,255,0.2) !important;*background-color: rgb(255,255,255) !important;}”][vc_column_text el_class=”pull-quote” css=”.vc_custom_1674854578803{margin-bottom: 0px !important;padding-right: 60px !important;padding-bottom: 0px !important;}”]Advocating for pathologists and patients <\/span>to protect the value, quality, and accessibility of laboratory services<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row fullwidth=”true” equal_columns=”true” attached=”true” css=”.vc_custom_1675110892956{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background: #ffffff url(https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_hero_t2x.jpg?id=5002) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1675110877939{padding-right: 0px !important;padding-left: 0px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” offset=”vc_col-lg-12 vc_hidden-lg vc_col-md-offset-0 vc_col-md-12 vc_hidden-md vc_col-sm-offset-0 vc_hidden-xs”][mk_padding_divider size=”300″][vc_row_inner css=”.vc_custom_1643159001231{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner width=”1\/4″ css=”.vc_custom_1643158661425{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][vc_empty_space height=”50px” css=”.vc_custom_1643159024911{padding-top: 0px !important;padding-bottom: 0px !important;}”][\/vc_column_inner][vc_column_inner width=”3\/4″ css=”.vc_custom_1645128089709{padding-top: 0px !important;padding-bottom: 0px !important;background-color: rgba(255,255,255,0.36) !important;*background-color: rgb(255,255,255) !important;}”][vc_empty_space height=”50px” css=”.vc_custom_1643159016702{margin-right: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row equal_columns=”true” attached=”true” css=”.vc_custom_1584032692153{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1614034302938{padding-right: 0px !important;padding-left: 0px !important;}” offset=”vc_hidden-lg vc_hidden-xs”][vc_row_inner css=”.vc_custom_1613163717047{padding-top: 15px !important;padding-bottom: 60px !important;background-color: #5d6770 !important;}”][vc_column_inner width=”1\/4″ css=”.vc_custom_1584546280057{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][\/vc_column_inner][vc_column_inner el_class=”image_quotes” width=”3\/4″ css=”.vc_custom_1613502623791{margin-top: -15px !important;margin-right: 0px !important;margin-left: 0px !important;padding-top: 35px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-color: rgba(255,255,255,0.2) !important;*background-color: rgb(255,255,255) !important;}”][vc_column_text el_class=”pull-quote” css=”.vc_custom_1674854679981{margin-bottom: 0px !important;padding-right: 50px !important;padding-bottom: 0px !important;}”]Advocating for pathologists and patients <\/span>to protect the value, quality, and accessibility of laboratory services<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row equal_columns=”true” attached=”true” css=”.vc_custom_1675110919631{margin-right: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background: #ffffff url(https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_hero_m2x.jpg?id=5001) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column css=”.vc_custom_1675110904799{padding-top: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” offset=”vc_hidden-lg vc_col-md-offset-0 vc_col-md-12 vc_hidden-md vc_col-sm-offset-0 vc_hidden-sm”][mk_padding_divider size=”146″][vc_row_inner css=”.vc_custom_1643159326810{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;padding-left: 20px !important;}”][vc_column_inner css=”.vc_custom_1584032770951{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-color: rgba(255,255,255,0.36) !important;*background-color: rgb(255,255,255) !important;}”][vc_empty_space height=”30px”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row equal_columns=”true” attached=”true” css=”.vc_custom_1643159133797{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;background-position: center !important;background-repeat: no-repeat !important;background-size: contain !important;}”][vc_column css=”.vc_custom_1613687903139{padding-top: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}” offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm”][vc_row_inner css=”.vc_custom_1613687909944{padding-top: 0px !important;padding-bottom: 50px !important;padding-left: 20px !important;background-color: #5d6770 !important;}”][vc_column_inner el_class=”pull-quote” css=”.vc_custom_1645128103570{margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: rgba(255,255,255,0.36) !important;*background-color: rgb(255,255,255) !important;}”][vc_column_text el_class=”image_quotes” css=”.vc_custom_1674854763890{padding-top: 35px !important;padding-right: 0px !important;}”]Advocating for pathologists and patients <\/span>to protect the value, quality, and accessibility of laboratory services<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1529440778887{background-color: #ffffff !important;}”][vc_column css=”.vc_custom_1614034253144{padding-right: 0px !important;padding-left: 0px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs”][vc_empty_space height=”80″][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1614033149153{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}” el_class=”.print”][vc_column width=”2\/3″ css=”.vc_custom_1614033984447{padding-right: 50px !important;padding-left: 100px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs” el_class=”.print”][vc_column_text css=”.vc_custom_1674855218470{margin-bottom: 0px !important;}”]\n

CAP Members Lobby to Stop Pay Cuts, Prepare for Pandemics, Address Workforce Shortages<\/h2>\n[\/vc_column_text][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1614033996248{padding-top: 100px !important;padding-right: 0px !important;padding-left: 0px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1614033149153{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}” el_class=”.print”][vc_column width=”2\/3″ css=”.vc_custom_1614033984447{padding-right: 50px !important;padding-left: 100px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs” el_class=”.print”][vc_column_text css=”.vc_custom_1674855390213{margin-bottom: 0px !important;}”]In 2022, a record-breaking number of CAP members (241) advocated to protect the value of pathology services while meeting with their federal legislators on Hill Day, part of the CAP\u2019s Pathologists Leadership Summit. Members discussed how Congress can mitigate Medicare cuts, alleviate medical workforce shortages, and ensure funding for future pandemic preparedness. The CAP scheduled more than 300 virtual meetings with congressional offices to discuss these priority issues for patients and the pathology specialty.<\/p>\n

The first hybrid Pathologists Leadership Summit met April 30 through May 3 both virtually and in Washington, DC, where participants attended special learning sessions, heard from keynote speakers, and prepped for meeting with their legislative representatives on Hill Day. Meeting content focused on new and emerging technologies, payment models, regulations, and issues currently impacting the specialty. The Pathologists Leadership Summit arms pathologists with the information they need to know as advocates and leaders in pathology, their community, and in their practices. Engagement and feedback from the meeting were overwhelmingly positive, with 99% of attendees saying they were satisfied or very satisfied with the experience and 96% reporting they would recommend the event to a colleague.<\/p>\n

Throughout 2022, the CAP fought to protect the value of pathology services by urging Congress to pass legislation stopping 2023 Medicare cuts of about 4% to pathologists. In addition to Hill Day, the CAP activated its grassroots network, planned another lobbying event in November, and utilized its political action committee, PathPAC, to reinforce our message and spur lawmakers to act. As a result, Congress opted to mitigate the cut by 2.5 percentage points in 2023 and to mitigate similar cuts planned for 2024 by 1.5 percentage points. Lawmakers also decided to delay Medicare cuts to clinical laboratory fees that were set to take effect in 2023 by one year.<\/p>\n

Pathologists also discussed the impact of COVID-19 on laboratories and pathologists and urged Congress to support the PREVENT Pandemics Act, which would strengthen the nation\u2019s public health, medical preparedness, and response systems in the wake of the COVID-19 pandemic. The bill was enacted later in the year.[\/vc_column_text][vc_column_text css=”.vc_custom_1675111756980{margin-bottom: 0px !important;}”]\n

CAP Tackles Health Inequity and Disparities<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1675111770660{margin-bottom: 0px !important;}”]The CAP established policy and supported legislation and regulatory actions to address social determinants of health (SDOH) and reduce health disparities in the United States. The Board of Governors adopted policies to increase access to health care coverage and recognize the role of SDOH on care disparities and inequities of care for patients. As experts of diagnostic testing and stewards of laboratory data, pathologists are uniquely positioned to both identify health disparities and develop plans to mitigate them in their communities. Collection, access, distribution, and utilization of SDOH data can help to reduce health disparities among patients and improve medical decision-making, health outcomes for patients, and public health.[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1643057389203{padding-right: 0px !important;padding-left: 80px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs”][vc_single_image image=”5269″ img_size=”full” alignment=”right”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1614033133705{margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 100px !important;padding-bottom: 0px !important;padding-left: 100px !important;background-color: #ffffff !important;}” el_class=”.print”][vc_column offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs” css=”.vc_custom_1614034341582{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}” el_class=”.print”][mk_page_section vertical_align=”center” min_height=”0″ padding_top=”0″ padding_bottom=”0″ sidebar=”sidebar-1″][\/mk_page_section][vc_row_inner css=”.vc_custom_1585176651154{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner css=”.vc_custom_1675115059420{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;background-image: url(https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_callout_dt2x.jpg?id=4997) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][mk_padding_divider size=”715″][vc_empty_space height=”15px” css=”.vc_custom_1551127002657{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][vc_empty_space height=”25px” css=”.vc_custom_1585177146246{margin-right: 65px !important;margin-left: 65px !important;background-color: rgba(52,175,203,0.32) !important;*background-color: rgb(52,175,203) !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner is_fullwidth_content=”false” css=”.vc_custom_1585176451991{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 80px !important;padding-bottom: 0px !important;padding-left: 80px !important;}”][vc_column_inner el_class=”.print” css=”.vc_custom_1614031824247{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;background-color: rgba(52,175,203,0.15) !important;*background-color: rgb(52,175,203) !important;}”][vc_empty_space height=”50″][vc_column_text css=”.vc_custom_1676913781497{margin-bottom: 0px !important;padding-right: 50px !important;padding-left: 50px !important;}”]In late 2022, Congress enacted CAP-endorsed provisions promoting clinical trial diversity. These provisions included revising guidance to promote diversity in clinical trials through action plans, the use of decentralized clinical studies, and expanding trials to better capture evidence on a variety of patients.<\/span>[\/vc_column_text][vc_empty_space height=”15px” css=”.vc_custom_1551127002657{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][vc_empty_space height=”25px”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1532122999046{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}”][vc_column css=”.vc_custom_1614034003807{padding-right: 80px !important;padding-left: 80px !important;}” offset=”vc_hidden-lg vc_hidden-xs”][vc_empty_space height=”60″][vc_column_text css=”.vc_custom_1674855218470{margin-bottom: 0px !important;}”]\n

CAP Members Lobby to Stop Pay Cuts, Prepare for Pandemics, Address Workforce Shortages<\/h2>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1674855492751{margin-bottom: 0px !important;}”]In 2022, a record-breaking number of CAP members (241) advocated to protect the value of pathology services while meeting with their federal legislators on Hill Day, part of the CAP\u2019s Pathologists Leadership Summit. Members discussed how Congress can mitigate Medicare cuts, alleviate medical workforce shortages, and ensure funding for future pandemic preparedness. The CAP scheduled more than 300 virtual meetings with congressional offices to discuss these priority issues for patients and the pathology specialty.[\/vc_column_text][vc_empty_space height=”30″][vc_single_image image=”5271″ img_size=”full” alignment=”center”][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1674855540778{margin-bottom: 0px !important;}”]The first hybrid Pathologists Leadership Summit met April 30 through May 3 both virtually and in Washington, DC, where participants attended special learning sessions, heard from keynote speakers, and prepped for meeting with their legislative representatives on Hill Day. Meeting content focused on new and emerging technologies, payment models, regulations, and issues currently impacting the specialty. The Pathologists Leadership Summit arms pathologists with the information they need to know as advocates and leaders in pathology, their community, and in their practices. Engagement and feedback from the meeting were overwhelmingly positive, with 99% of attendees saying they were satisfied or very satisfied with the experience and 96% reporting they would recommend the event to a colleague.<\/p>\n

Throughout 2022, the CAP fought to protect the value of pathology services by urging Congress to pass legislation stopping 2023 Medicare cuts of about 4% to pathologists. In addition to Hill Day, the CAP activated its grassroots network, planned another lobbying event in November, and utilized its political action committee, PathPAC, to reinforce our message and spur lawmakers to act. As a result, Congress opted to mitigate the cut by 2.5 percentage points in 2023 and to mitigate similar cuts planned for 2024 by 1.5 percentage points. Lawmakers also decided to delay Medicare cuts to clinical laboratory fees that were set to take effect in 2023 by one year.<\/p>\n

Pathologists also discussed the impact of COVID-19 on laboratories and pathologists and urged Congress to support the PREVENT Pandemics Act, which would strengthen the nation\u2019s public health, medical preparedness, and response systems in the wake of the COVID-19 pandemic. The bill was enacted later in the year.[\/vc_column_text][vc_column_text css=”.vc_custom_1674855747812{margin-bottom: 0px !important;}”]\n

CAP Tackles Health Inequity and Disparities<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1674855737336{margin-bottom: 0px !important;}”]The CAP established policy and supported legislation and regulatory actions to address social determinants of health (SDOH) and reduce health disparities in the United States. The Board of Governors adopted policies to increase access to health care coverage and recognize the role of SDOH on care disparities and inequities of care for patients. As experts of diagnostic testing and stewards of laboratory data, pathologists are uniquely positioned to both identify health disparities and develop plans to mitigate them in their communities. Collection, access, distribution, and utilization of SDOH data can help to reduce health disparities among patients and improve medical decision-making, health outcomes for patients, and public health.[\/vc_column_text][vc_empty_space height=”20″][\/vc_column][\/vc_row][vc_row fullwidth=”true” css=”.vc_custom_1613693388316{margin-right: 0px !important;margin-left: 0px !important;padding-right: 80px !important;padding-left: 80px !important;background-color: #ffffff !important;}”][vc_column offset=”vc_hidden-lg vc_hidden-xs” css=”.vc_custom_1643156640649{padding-top: 0px !important;padding-right: 80px !important;padding-bottom: 0px !important;padding-left: 80px !important;}”][vc_empty_space height=”20px”][mk_page_section vertical_align=”top” min_height=”0″ full_width=”true” padding_top=”0″ padding_bottom=”0″ sidebar=”sidebar-1″][\/mk_page_section][vc_row_inner css=”.vc_custom_1613673231942{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][vc_column_inner css=”.vc_custom_1675178285333{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-image: url(https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_callout_t2x.jpg?id=4999) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][mk_padding_divider size=”312″][vc_empty_space height=”15px” css=”.vc_custom_1613673360486{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][vc_empty_space height=”25px” css=”.vc_custom_1613693546180{margin-right: 70px !important;margin-left: 70px !important;background-color: rgba(52,175,203,0.32) !important;*background-color: rgb(52,175,203) !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner is_fullwidth_content=”false” css=”.vc_custom_1613693521806{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 70px !important;padding-bottom: 0px !important;padding-left: 70px !important;}”][vc_column_inner css=”.vc_custom_1613672183482{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-color: rgba(52,175,203,0.15) !important;*background-color: rgb(52,175,203) !important;}”][vc_empty_space height=”30″][vc_column_text css=”.vc_custom_1676913798091{margin-bottom: 0px !important;padding-right: 50px !important;padding-left: 50px !important;}”]In late 2022, Congress enacted CAP-endorsed provisions promoting clinical trial diversity. These provisions included revising guidance to promote diversity in clinical trials through action plans, the use of decentralized clinical studies, and expanding trials to better capture evidence on a variety of patients.<\/span>[\/vc_column_text][vc_empty_space height=”15px” css=”.vc_custom_1551127002657{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1553024465763{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}”][vc_column css=”.vc_custom_1553024585996{margin-bottom: 0px !important;padding-right: 20px !important;padding-left: 20px !important;}” offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm”][vc_empty_space height=”50px”][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675111517423{margin-bottom: 0px !important;}”]\n

CAP Members Lobby to Stop Pay Cuts, Prepare for Pandemics, Address Workforce Shortages<\/h2>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675111603149{margin-bottom: 0px !important;}”]In 2022, a record-breaking number of CAP members (241) advocated to protect the value of pathology services while meeting with their federal legislators on Hill Day, part of the CAP\u2019s Pathologists Leadership Summit.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1553025093885{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore1″][vc_tta_section title=”Read More” tab_id=”1532364006045-f0064afe-c964″ el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675111616739{margin-bottom: 0px !important;}”]Members discussed how Congress can mitigate Medicare cuts, alleviate medical workforce shortages, and ensure funding for future pandemic preparedness. The CAP scheduled more than 300 virtual meetings with congressional offices to discuss these priority issues for patients and the pathology specialty.[\/vc_column_text][vc_empty_space height=”24px”][vc_single_image image=”5270″ img_size=”full” alignment=”center”][vc_empty_space height=”16px”][vc_column_text css=”.vc_custom_1675111643899{margin-bottom: 0px !important;}”]The first hybrid Pathologists Leadership Summit met April 30 through May 3 both virtually and in Washington, DC, where participants attended special learning sessions, heard from keynote speakers, and prepped for meeting with their legislative representatives on Hill Day. Meeting content focused on new and emerging technologies, payment models, regulations, and issues currently impacting the specialty. The Pathologists Leadership Summit arms pathologists with the information they need to know as advocates and leaders in pathology, their community, and in their practices. Engagement and feedback from the meeting were overwhelmingly positive, with 99% of attendees saying they were satisfied or very satisfied with the experience and 96% reporting they would recommend the event to a colleague.<\/p>\n

Throughout 2022, the CAP fought to protect the value of pathology services by urging Congress to pass legislation stopping 2023 Medicare cuts of about 4% to pathologists. In addition to Hill Day, the CAP activated its grassroots network, planned another lobbying event in November, and utilized its political action committee, PathPAC, to reinforce our message and spur lawmakers to act. As a result, Congress opted to mitigate the cut by 2.5 percentage points in 2023 and to mitigate similar cuts planned for 2024 by 1.5 percentage points. Lawmakers also decided to delay Medicare cuts to clinical laboratory fees that were set to take effect in 2023 by one year.<\/p>\n

Pathologists also discussed the impact of COVID-19 on laboratories and pathologists and urged Congress to support the PREVENT Pandemics Act, which would strengthen the nation\u2019s public health, medical preparedness, and response systems in the wake of the COVID-19 pandemic. The bill was enacted later in the year.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675187765118{margin-bottom: 0px !important;}”]\n

CAP Tackles Health Inequity and Disparities<\/h3>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675187784407{margin-bottom: 0px !important;}”]The CAP established policy and supported legislation and regulatory actions to address social determinants of health (SDOH) and reduce health disparities in the United States.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1553025093885{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore1″][vc_tta_section title=”Read More” tab_id=”1643160704098-d2ae9a9c-7c2b” el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675187811719{margin-bottom: 0px !important;}”]The Board of Governors adopted policies to increase access to health care coverage and recognize the role of SDOH on care disparities and inequities of care for patients. As experts of diagnostic testing and stewards of laboratory data, pathologists are uniquely positioned to both identify health disparities and develop plans to mitigate them in their communities. Collection, access, distribution, and utilization of SDOH data can help to reduce health disparities among patients and improve medical decision-making, health outcomes for patients, and public health.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row fullwidth=”true” css=”.vc_custom_1613672255637{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}”][vc_column offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm” css=”.vc_custom_1613672051586{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][mk_page_section vertical_align=”top” min_height=”0″ full_width=”true” padding_top=”0″ padding_bottom=”0″ sidebar=”sidebar-1″][\/mk_page_section][vc_row_inner css=”.vc_custom_1585176651154{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner css=”.vc_custom_1675178366697{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-image: url(https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_callout_m2x.jpg?id=4998) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][mk_padding_divider size=”230″][vc_empty_space height=”15px” css=”.vc_custom_1551127002657{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][vc_empty_space height=”25px” css=”.vc_custom_1613673792028{margin-right: 20px !important;margin-left: 20px !important;background-color: rgba(52,175,203,0.32) !important;*background-color: rgb(52,175,203) !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner is_fullwidth_content=”false” css=”.vc_custom_1613673803604{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-right: 20px !important;padding-bottom: 0px !important;padding-left: 20px !important;}”][vc_column_inner css=”.vc_custom_1585177052410{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;background-color: rgba(52,175,203,0.15) !important;*background-color: rgb(52,175,203) !important;}”][vc_empty_space height=”30″][vc_column_text css=”.vc_custom_1676913816734{margin-bottom: 0px !important;padding-right: 20px !important;padding-left: 20px !important;}”]In late 2022, Congress enacted CAP-endorsed provisions promoting clinical trial diversity. These provisions included revising guidance to promote diversity in clinical trials through action plans, the use of decentralized clinical studies, and expanding trials to better capture evidence on a variety of patients.<\/span>[\/vc_column_text][vc_empty_space height=”15px” css=”.vc_custom_1551127002657{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1675114896697{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}” el_class=”.print”][vc_column width=”2\/3″ css=”.vc_custom_1614033984447{padding-right: 50px !important;padding-left: 100px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs” el_class=”.print”][vc_empty_space height=”60px”][vc_column_text css=”.vc_custom_1674856044385{margin-bottom: 0px !important;}”]\n

Pathologists Quality Registry Enrollment Increases<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1674856060616{margin-bottom: 0px !important;}”]In 2022, the Pathologists Quality Registry\u2019s enrollment increased more than 20% from the previous year to more than 1,350 pathologists. As the registry continues to grow, it is also developing and maintaining quality reporting measures that create a scoring advantage for pathologists as Medicare\u2019s Merit-based Incentive Payment System (MIPS) program gets more stringent. CAP experts also provided registry users with practice-specific guidance on MIPS reporting to ensure that the CAP’s registry is the market leader for pathology practices.[\/vc_column_text][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1674856146008{margin-bottom: 0px !important;}”]\n

CAP Advocates for New Digital Pathology Codes<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1676913671992{margin-bottom: 0px !important;}”]The CAP successfully advocated for the inclusion of new Current Procedural Terminology (CPT) digital pathology codes. Through its advocacy, the CAP worked with the American Medical Association (AMA) CPT Editorial Panel to add 13 new digital pathology add-on codes<\/a>. The new codes will help pathologists, pathology practices, and laboratories providing digital pathology digitization procedures report these services appropriately. The new digital pathology Category III CPT codes will be used to report additional clinical staff work and service requirements associated with digitizing glass microscope slides for primary diagnosis. The AMA CPT is also adding new guidelines in the Category III section to define digital pathology digitization procedures. To help pathologists report the codes correctly, the CAP developed educational resources for members. The new codes went into effect on January 1, 2023.[\/vc_column_text][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1674856183097{margin-bottom: 0px !important;}”]\n

CAP and CDC Sign Memorandum of Understanding<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1674856194535{margin-bottom: 0px !important;}”]The CAP signed a memorandum of understanding (MOU) with the Centers for Disease Control and Prevention (CDC) to provide assistance and expertise with diagnostic surge testing during public health emergencies. Under the memorandum, the CAP will collaborate with the CDC, government agencies, and other partners to support surge testing capacity when public health threats and emergencies arise. The CAP will serve as a communications hub between CAP member experts, CAP committees, and entities participating in the MOU. For example, the CAP can leverage its accredited laboratories to assist with external surge testing capacity. The CAP can also collect capability data from laboratories to identify those with the capacity to support a national response, including community-based testing for vulnerable patient communities.[\/vc_column_text][vc_empty_space height=”80px”][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1643057389203{padding-right: 0px !important;padding-left: 80px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1532122999046{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}”][vc_column css=”.vc_custom_1614034003807{padding-right: 80px !important;padding-left: 80px !important;}” offset=”vc_hidden-lg vc_hidden-xs”][vc_empty_space height=”60″][vc_column_text css=”.vc_custom_1675178800208{margin-bottom: 0px !important;}”]\n

Pathologists Quality Registry Enrollment Increases<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1675178814238{margin-bottom: 0px !important;}”]In 2022, the Pathologists Quality Registry\u2019s enrollment increased more than 20% from the previous year to more than 1,350 pathologists. As the registry continues to grow, it is also developing and maintaining quality reporting measures that create a scoring advantage for pathologists as Medicare\u2019s Merit-based Incentive Payment System (MIPS) program gets more stringent. CAP experts also provided registry users with practice-specific guidance on MIPS reporting to ensure that the CAP’s registry is the market leader for pathology practices.[\/vc_column_text][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1675178825360{margin-bottom: 0px !important;}”]\n

CAP Advocates for New Digital Pathology Codes<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1676913699057{margin-bottom: 0px !important;}”]The CAP successfully advocated for the inclusion of new Current Procedural Terminology (CPT) digital pathology codes. Through its advocacy, the CAP worked with the American Medical Association (AMA) CPT Editorial Panel to add 13 new digital pathology add-on codes<\/a>. The new codes will help pathologists, pathology practices, and laboratories providing digital pathology digitization procedures report these services appropriately. The new digital pathology Category III CPT codes will be used to report additional clinical staff work and service requirements associated with digitizing glass microscope slides for primary diagnosis. The AMA CPT is also adding new guidelines in the Category III section to define digital pathology digitization procedures. To help pathologists report the codes correctly, the CAP developed educational resources for members. The new codes went into effect on January 1, 2023.[\/vc_column_text][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1675178868167{margin-bottom: 0px !important;}”]\n

CAP and CDC Sign Memorandum of Understanding<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1675178879528{margin-bottom: 0px !important;}”]The CAP signed a memorandum of understanding (MOU) with the Centers for Disease Control and Prevention (CDC) to provide assistance and expertise with diagnostic surge testing during public health emergencies. Under the memorandum, the CAP will collaborate with the CDC, government agencies, and other partners to support surge testing capacity when public health threats and emergencies arise. The CAP will serve as a communications hub between CAP member experts, CAP committees, and entities participating in the MOU. For example, the CAP can leverage its accredited laboratories to assist with external surge testing capacity. The CAP can also collect capability data from laboratories to identify those with the capacity to support a national response, including community-based testing for vulnerable patient communities.[\/vc_column_text][vc_empty_space height=”20″][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1553024465763{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}”][vc_column css=”.vc_custom_1553024585996{margin-bottom: 0px !important;padding-right: 20px !important;padding-left: 20px !important;}” offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm”][vc_empty_space height=”50px”][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675187841260{margin-bottom: 0px !important;}”]\n

Pathologists Quality Registry Enrollment Increases<\/h3>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675187858863{margin-bottom: 0px !important;}”]In 2022, the Pathologists Quality Registry\u2019s enrollment increased more than 20% from the previous year to more than 1,350 pathologists.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1553025093885{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore1″][vc_tta_section title=”Read More” tab_id=”1675188137586-5442c21f-46da” el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675187875761{margin-bottom: 0px !important;}”]As the registry continues to grow, it is also developing and maintaining quality reporting measures that create a scoring advantage for pathologists as Medicare\u2019s Merit-based Incentive Payment System (MIPS) program gets more stringent. CAP experts also provided registry users with practice-specific guidance on MIPS reporting to ensure that the CAP’s registry is the market leader for pathology practices.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675187903476{margin-bottom: 0px !important;}”]\n

CAP Advocates for New Digital Pathology Codes<\/h3>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1676913724313{margin-bottom: 0px !important;}”]The CAP successfully advocated for the inclusion of new Current Procedural Terminology (CPT) digital pathology codes. Through its advocacy, the CAP worked with the American Medical Association (AMA) CPT Editorial Panel to add 13 new digital pathology add-on codes<\/a>.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1553025093885{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore1″][vc_tta_section title=”Read More” tab_id=”1675188146588-62dafa8b-17b0″ el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675187955329{margin-bottom: 0px !important;}”]The new codes will help pathologists, pathology practices, and laboratories providing digital pathology digitization procedures report these services appropriately. The new digital pathology Category III CPT codes will be used to report additional clinical staff work and service requirements associated with digitizing glass microscope slides for primary diagnosis. The AMA CPT is also adding new guidelines in the Category III section to define digital pathology digitization procedures. To help pathologists report the codes correctly, the CAP developed educational resources for members. The new codes went into effect on January 1, 2023.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675188404483{margin-bottom: 0px !important;}”]\n

CAP and CDC Sign Memorandum of Understanding<\/h3>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675188433689{margin-bottom: 0px !important;}”]The CAP signed a memorandum of understanding (MOU) with the Centers for Disease Control and Prevention (CDC) to provide assistance and expertise with diagnostic surge testing during public health emergencies.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1553025093885{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore1″][vc_tta_section title=”Read More” tab_id=”1675188360866-4c2475e7-b8b6″ el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675188460261{margin-bottom: 0px !important;}”]Under the memorandum, the CAP will collaborate with the CDC, government agencies, and other partners to support surge testing capacity when public health threats and emergencies arise. The CAP will serve as a communications hub between CAP member experts, CAP committees, and entities participating in the MOU. For example, the CAP can leverage its accredited laboratories to assist with external surge testing capacity. The CAP can also collect capability data from laboratories to identify those with the capacity to support a national response, including community-based testing for vulnerable patient communities.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1674856233306{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #f2fafc !important;}” el_class=”.print”][vc_column width=”2\/3″ css=”.vc_custom_1614033984447{padding-right: 50px !important;padding-left: 100px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs” el_class=”.print”][vc_empty_space height=”80px”][vc_column_text css=”.vc_custom_1674856263488{margin-bottom: 0px !important;}”]\n

Medical Specialty Group Awards CAP Advocacy $100,000 Grant<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1674856277830{margin-bottom: 0px !important;}”]On September 29, the Council of Medical Specialty Societies, a coalition of 48 specialty societies representing more than 800,000 physicians across health care, awarded the College of American Pathologists and 10 other member specialty societies grants of $100,000 each to promote diagnostic excellence in medicine. In its grant application, the CAP proposed to improve diagnostic excellence by first understanding, and ultimately improving, the patient experience with pathology reports. In partnership with colorectal cancer advocacy groups, the CAP will engage patients to identify areas of concern and confusion in pathology reports for the diagnosis of colon cancer.[\/vc_column_text][vc_empty_space height=”80px”][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1675115247665{padding-right: 0px !important;padding-left: 50px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs”][vc_empty_space height=”60px”][mk_image src=”https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_icon_people-stars_dt.svg” image_size=”full” align=”center”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1675115336357{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #f2fafc !important;}” el_class=”.print”][vc_column css=”.vc_custom_1643156624662{padding-right: 80px !important;padding-left: 80px !important;}” offset=”vc_hidden-lg vc_hidden-xs” el_class=”.print”][vc_empty_space height=”60px”][vc_column_text css=”.vc_custom_1675115278583{margin-bottom: 0px !important;}”]\n

Medical Specialty Group Awards CAP Advocacy $100,000 Grant<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1675115292488{margin-bottom: 0px !important;}”]On September 29, the Council of Medical Specialty Societies, a coalition of 48 specialty societies representing more than 800,000 physicians across health care, awarded the College of American Pathologists and 10 other member specialty societies grants of $100,000 each to promote diagnostic excellence in medicine. In its grant application, the CAP proposed to improve diagnostic excellence by first understanding, and ultimately improving, the patient experience with pathology reports. In partnership with colorectal cancer advocacy groups, the CAP will engage patients to identify areas of concern and confusion in pathology reports for the diagnosis of colon cancer.[\/vc_column_text][mk_image src=”https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_icon_people-stars_dt.svg” image_size=”full” align=”center”][vc_empty_space height=”40px”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1675115346266{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #f2fafc !important;}”][vc_column css=”.vc_custom_1643220836784{margin-bottom: 0px !important;padding-right: 20px !important;padding-left: 20px !important;}” offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm”][vc_empty_space][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675188575664{margin-bottom: 0px !important;}”]\n

Medical Specialty Group Awards CAP Advocacy $100,000 Grant<\/h3>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675188617069{margin-bottom: 0px !important;}”]On September 29, the Council of Medical Specialty Societies, a coalition of 48 specialty societies representing more than 800,000 physicians across health care, awarded the College of American Pathologists and 10 other member specialty societies grants of $100,000 each to promote diagnostic excellence in medicine.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1675188893144{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore2″][vc_tta_section title=”Read More” tab_id=”1643220746003-8c5da229-9868″ el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675188633037{margin-bottom: 0px !important;}”]In its grant application, the CAP proposed to improve diagnostic excellence by first understanding, and ultimately improving, the patient experience with pathology reports. In partnership with colorectal cancer advocacy groups, the CAP will engage patients to identify areas of concern and confusion in pathology reports for the diagnosis of colon cancer.[\/vc_column_text][mk_image src=”https:\/\/annualreport2022.ddev.site\/wp-content\/uploads\/policy_icon_people-stars_dt.svg” image_size=”full” align=”center”][\/vc_tta_section][\/vc_tta_accordion][vc_empty_space][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1529440778887{background-color: #ffffff !important;}”][vc_column width=”2\/3″ css=”.vc_custom_1643157002572{padding-right: 50px !important;padding-left: 100px !important;}” offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs”][vc_empty_space height=”60px”][vc_column_text css=”.vc_custom_1674856312593{margin-bottom: 0px !important;}”]\n

CAP Pushes Back on FDA Emergency Use Authorization Process<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1674856328250{margin-bottom: 0px !important;}”]CAP President Emily E. Volk, MD, FCAP, and Jonathan L. Myles, MD, FCAP, Council on Government and Professional Affairs chair, met with FDA staff on September 19 to discuss pathologists\u2019 concerns with the FDA\u2019s Emergency Use Authorization (EUA) process, including delays, burdens on laboratories, and costs. Dr. Volk and Dr. Myles specifically requested input from the FDA on how they plan to address delays, as new submissions can take up to a year for review; how to increase and improve communication with laboratories; the regulatory process for COVID-19 laboratory-developed tests (LDTs) when the EUA process is rescinded; and how the CAP can engage with the FDA on solutions. As a result of the meeting, the CAP and FDA presented a webinar on the topic for CAP members.[\/vc_column_text][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1674856346067{margin-bottom: 0px !important;}”]\n

CAP Engages Congress on the VALID Act<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1674856361294{margin-bottom: 0px !important;}”]Throughout 2022, the CAP lobbied in support of legislation to create a new comprehensive regulatory framework for clinical laboratory tests that includes LDTs. Many provisions in the Verifying Accurate Leading-edge IVCT Development (VALID) Act aligned with the CAP\u2019s long-held position for LDT oversight: ensure quality tests for patients, allow for innovation, and minimize burden on laboratories. The CAP lobbied for key provisions in the bill to achieve these goals, such as mandates to avoid regulatory duplication between federal agencies and streamlined regulatory pathways for new tests that maintain patient access while also ensuring quality. Importantly, the CAP worked with patient groups to support the bill and kept its members informed on the bill\u2019s progress.[\/vc_column_text][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1674856378461{margin-bottom: 0px !important;}”]\n

PathPAC Amplifies the Voice of Pathologists<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1674856393552{margin-bottom: 0px !important;}”]PathPAC is nonpartisan and represents the interests of pathologists on Capitol Hill through political and financial means. As a 501(c)(6) nonprofit, the CAP is the only pathologists\u2019 association with a federal political action committee strictly representing the interests of pathologists. In this capacity, the CAP advances the legislative agenda set by the Council on Government and Professional Affairs.<\/p>\n

During 2022, PathPAC created additional opportunities for pathologists to engage with their representatives and senators on the political issues concerning the specialty. PathPAC raised $200,301 and disbursed $209,500 to 80 congressional candidates.[\/vc_column_text][vc_empty_space height=”60″][\/vc_column][vc_column width=”1\/3″ offset=”vc_hidden-md vc_hidden-sm vc_hidden-xs”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1529440778887{background-color: #ffffff !important;}”][vc_column css=”.vc_custom_1643156991333{padding-right: 80px !important;padding-left: 80px !important;}” offset=”vc_hidden-lg vc_hidden-xs”][vc_empty_space height=”60px”][vc_column_text css=”.vc_custom_1675179406563{margin-bottom: 0px !important;}”]\n

CAP Pushes Back on FDA Emergency Use Authorization Process<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1675179419096{margin-bottom: 0px !important;}”]CAP President Emily E. Volk, MD, FCAP, and Jonathan L. Myles, MD, FCAP, Council on Government and Professional Affairs chair, met with FDA staff on September 19 to discuss pathologists\u2019 concerns with the FDA\u2019s Emergency Use Authorization (EUA) process, including delays, burdens on laboratories, and costs. Dr. Volk and Dr. Myles specifically requested input from the FDA on how they plan to address delays, as new submissions can take up to a year for review; how to increase and improve communication with laboratories; the regulatory process for COVID-19 laboratory-developed tests (LDTs) when the EUA process is rescinded; and how the CAP can engage with the FDA on solutions. As a result of the meeting, the CAP and FDA presented a webinar on the topic for CAP members.[\/vc_column_text][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1675179440733{margin-bottom: 0px !important;}”]\n

CAP Engages Congress on the VALID Act<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1675179454236{margin-bottom: 0px !important;}”]Throughout 2022, the CAP lobbied in support of legislation to create a new comprehensive regulatory framework for clinical laboratory tests that includes LDTs. Many provisions in the Verifying Accurate Leading-edge IVCT Development (VALID) Act aligned with the CAP\u2019s long-held position for LDT oversight: ensure quality tests for patients, allow for innovation, and minimize burden on laboratories. The CAP lobbied for key provisions in the bill to achieve these goals, such as mandates to avoid regulatory duplication between federal agencies and streamlined regulatory pathways for new tests that maintain patient access while also ensuring quality. Importantly, the CAP worked with patient groups to support the bill and kept its members informed on the bill\u2019s progress.[\/vc_column_text][vc_empty_space height=”20″][vc_column_text css=”.vc_custom_1675179471691{margin-bottom: 0px !important;}”]\n

PathPAC Amplifies the Voice of Pathologists<\/h3>\n[\/vc_column_text][vc_column_text css=”.vc_custom_1675179490802{margin-bottom: 0px !important;}”]PathPAC is nonpartisan and represents the interests of pathologists on Capitol Hill through political and financial means. As a 501(c)(6) nonprofit, the CAP is the only pathologists\u2019 association with a federal political action committee strictly representing the interests of pathologists. In this capacity, the CAP advances the legislative agenda set by the Council on Government and Professional Affairs.<\/p>\n

During 2022, PathPAC created additional opportunities for pathologists to engage with their representatives and senators on the political issues concerning the specialty. PathPAC raised $200,301 and disbursed $209,500 to 80 congressional candidates.[\/vc_column_text][vc_empty_space height=”60″][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1553024465763{margin-bottom: 0px !important;padding-right: 0px !important;padding-left: 0px !important;background-color: #ffffff !important;}”][vc_column css=”.vc_custom_1553024585996{margin-bottom: 0px !important;padding-right: 20px !important;padding-left: 20px !important;}” offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm”][vc_empty_space height=”60″][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675189078798{margin-bottom: 0px !important;}”]\n

CAP Pushes Back on FDA Emergency Use Authorization Process<\/h3>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675189118547{margin-bottom: 0px !important;}”]CAP President Emily E. Volk, MD, FCAP, and Jonathan L. Myles, MD, FCAP, Council on Government and Professional Affairs chair, met with FDA staff on September 19 to discuss pathologists\u2019 concerns with the FDA\u2019s Emergency Use Authorization (EUA) process.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1553025093885{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore1″][vc_tta_section title=”Read More” tab_id=”1612906991971-c090ae9d-dd12″ el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675189140314{margin-bottom: 0px !important;}”]Those concerns include delays, burdens on laboratories, and costs. Dr. Volk and Dr. Myles specifically requested input from the FDA on how they plan to address delays, as new submissions can take up to a year for review; how to increase and improve communication with laboratories; the regulatory process for COVID-19 laboratory-developed tests (LDTs) when the EUA process is rescinded; and how the CAP can engage with the FDA on solutions. As a result of the meeting, the CAP and FDA presented a webinar on the topic for CAP members.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675189166164{margin-bottom: 0px !important;}”]\n

CAP Engages Congress on the VALID Act<\/h3>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675189183933{margin-bottom: 0px !important;}”]Throughout 2022, the CAP lobbied in support of legislation to create a new comprehensive regulatory framework for clinical laboratory tests that includes LDTs.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1553025093885{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore1″][vc_tta_section title=”Read More” tab_id=”1643221754332-95885ddd-ab8e” el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675189202647{margin-bottom: 0px !important;}”]Many provisions in the Verifying Accurate Leading-edge IVCT Development (VALID) Act aligned with the CAP\u2019s long-held position for LDT oversight: ensure quality tests for patients, allow for innovation, and minimize burden on laboratories. The CAP lobbied for key provisions in the bill to achieve these goals, such as mandates to avoid regulatory duplication between federal agencies and streamlined regulatory pathways for new tests that maintain patient access while also ensuring quality. Importantly, the CAP worked with patient groups to support the bill and kept its members informed on the bill\u2019s progress.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675189223138{margin-bottom: 0px !important;}”]\n

PathPAC Amplifies the Voice of Pathologists<\/h3>\n[\/vc_column_text][vc_column_text el_class=”mobile_title” css=”.vc_custom_1675189326247{margin-bottom: 0px !important;}”]During 2022, PathPAC created additional opportunities for pathologists to engage with their representatives and senators on the political issues concerning the specialty, raising $200,301 and disbursing $209,500 to 80 congressional candidates.[\/vc_column_text][vc_tta_accordion style=”flat” shape=”square” color=”white” active_section=”0″ no_fill=”true” collapsible_all=”true” css=”.vc_custom_1553025093885{margin-top: 0px !important;padding-top: 0px !important;}” el_class=”accordion_readmore1″][vc_tta_section title=”Read More” tab_id=”1643222048325-15e07a70-9443″ el_class=”accordion_readmore”][vc_column_text css=”.vc_custom_1675189277142{margin-bottom: 0px !important;}”]PathPAC is nonpartisan and represents the interests of pathologists on Capitol Hill through political and financial means. As a 501(c)(6) nonprofit, the CAP is the only pathologists\u2019 association with a federal political action committee strictly representing the interests of pathologists. In this capacity, the CAP advances the legislative agenda set by the Council on Government and Professional Affairs.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1613506495474{background-color: #f2fafc !important;}”][vc_column css=”.vc_custom_1613505223264{padding-right: 0px !important;padding-left: 0px !important;}” offset=”vc_hidden-sm vc_hidden-xs”][vc_empty_space height=”80px”][vc_row_inner][vc_column_inner width=”2\/3″ css=”.vc_custom_1675117862897{padding-right: 50px !important;padding-left: 100px !important;}”][vc_column_text css=”.vc_custom_1675115617952{margin-bottom: 0px !important;}”]\n

State Pathology Society Partnerships Strengthen the Specialty<\/h3>\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″ css=”.vc_custom_1675117875233{padding-right: 0px !important;padding-left: 50px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”2\/3″ css=”.vc_custom_1675117747259{padding-right: 50px !important;padding-left: 100px !important;}”][vc_column_text css=”.vc_custom_1675115738789{margin-bottom: 0px !important;}”]The CAP partners with state pathology societies on a variety of issues to bolster advocacy efforts at the state and federal levels. In addition, the CAP has a strategic state pathology society initiative that provides support to help societies grow and thrive. As part of this initiative, the CAP has developed several tools and resources to assist societies to recruit and retain members, raise funds for lobbying, host virtual meetings, and prepare society members to engage on state-level advocacy activities.<\/p>\n

In 2022, the CAP collaborated with societies from across the country to protect pathologists\u2019 scope of practice, patient access to pathology services, and fair pay. Key highlights include the following:<\/p>\n